Tag: Vaccines
Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
Decrease Seen in Child Vaccination Coverage During COVID-19
Up-to-date status for all recommended vaccines down to 49.7 percent among children aged 5 months
Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response
Findings from early-stage trial that started in March and included eight healthy people receiving two doses
NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July
About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
Children of Mothers With Mental Illness Less Likely to Receive Vaccines
Risk highest for children living with mothers with alcohol or substance misuse disorders
Plan in Place to Up Production of Prefilled Syringes for Future COVID-19 Vaccine
Project Jumpstart aims to produce 100 million prefilled syringes by the end of 2020 and more than 500 million in 2021
Pediatric Vaccine Ordering Has Decreased During COVID-19
Decrease seen in VFC-funded APIC-recommended childhood vaccines after national emergency declaration
Human Trials of Experimental COVID-19 Vaccine Begin in U.S.
If effective, vaccine could be available for emergency use in the United States as early as September
National Coronavirus Testing Strategy Announced as U.S. Cases Top 1 Million
And, potential vaccine against COVID-19 shows promise, could begin human testing within a few weeks
